Topline
Novo Nordisk has launched a multi-month subscription program meant to lower the price of the weight loss drug for patients who subscribe to three-, six- or 12-month programs for either the pill or injectable version of the medication.
Wegovy brand injections.
dpa/picture alliance via Getty Images
Key Facts
The subscription program became available Monday to patients who are prescribed Wegovy through third-party telehealth providers like Ro, WeightWatchers, LifeMC, with Hims & Hers and Sesame, with Novo Nordisk promising other providers will be able to offer the subscription program soon.
Novo Nordisk stock was up about 1.5% in premarket on the news.
This is a developing story and will be updated.
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here: joinsubtext.com/forbes.